Skip to main content
. 2022 Jan 4;2022:3109165. doi: 10.1155/2022/3109165

Table 2.

Kaplan–Meier survival analysis and log-rank test compared in the clinical pathological stage.

Characteristics Stage I-II Stage III-IV
N Mean OS (months) X 2 P value N Mean OS (months) X 2 P value
NLR Low 94 54.2 10.7 0.001 82 43.9 4.9 0.027
High 69 41.4 85 34

PLR Low 80 54.1 7.4 0.007 68 42.9 2.2 0.139
High 83 44.9 99 35.5

CEA (ng/mL) Low 140 49.8 0.7 0.383 104 44.9 12.4 <0.001
High 23 43.9 63 29.5

CEA + NLR Low 83 54.4 8.6 0.003 58 49.6 12.1 0.001
High 80 42.9 109 33.2

CEA + PLR Low 71 53.7 5.2 0.023 46 47.4 5.6 0.018
High 92 45.9 121 35.4

NLR + PLR Low 64 56.2 9.9 0.002 52 46.2 4.9 0.027
High 99 44.7 115 35.3

CEA + NLR + PLR Low 58 55.6 7.2 0.007 36 52.4 9.5 0.002
High 105 45.6 131 35